PMCB
PharmaCyte BiotechDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
PMCB vs peer average
48/100
PMCB vs. peer average (D vs. D)
Grade spread
B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
DRMA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $3.74M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PMCB
PharmaCyte Biotech
DRMA
Dermata Therapeutics
Grade
D
B
Momentum
19
50
Value
55
59
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs DRMA
PMCB / DRMA
Grade Position
In line
PMCB vs. peer average (D vs. D)
48/100
Momentum
19
DRMAValue
55
DRMASentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PMCB
DRMA is the first peer returned for this comparison set.